Amedisys, Inc. (NASDAQ:AMED) Shares Purchased by New York Life Investment Management LLC

New York Life Investment Management LLC grew its stake in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 22.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 93,992 shares of the health services provider's stock after purchasing an additional 17,149 shares during the quarter. New York Life Investment Management LLC owned approximately 0.29% of Amedisys worth $8,935,000 as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. Cetera Trust Company N.A bought a new stake in Amedisys during the 4th quarter worth $215,000. CWM LLC boosted its holdings in Amedisys by 40.4% in the fourth quarter. CWM LLC now owns 2,629 shares of the health services provider's stock valued at $250,000 after acquiring an additional 757 shares during the last quarter. Contravisory Investment Management Inc. acquired a new stake in Amedisys during the 4th quarter valued at approximately $258,000. Argonautica Private Wealth Management Inc. raised its holdings in Amedisys by 6.1% during the 3rd quarter. Argonautica Private Wealth Management Inc. now owns 3,003 shares of the health services provider's stock worth $280,000 after purchasing an additional 172 shares during the last quarter. Finally, Federated Hermes Inc. boosted its stake in shares of Amedisys by 32.9% in the 4th quarter. Federated Hermes Inc. now owns 3,518 shares of the health services provider's stock valued at $334,000 after purchasing an additional 871 shares during the last quarter. Institutional investors own 94.36% of the company's stock.

Amedisys Stock Performance

AMED traded down $0.35 during trading on Friday, hitting $92.08. 246,612 shares of the company traded hands, compared to its average volume of 273,222. Amedisys, Inc. has a one year low of $73.10 and a one year high of $96.44. The stock's fifty day moving average is $92.40 and its 200 day moving average is $93.33. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.31. The firm has a market cap of $3.01 billion, a P/E ratio of -143.88, a price-to-earnings-growth ratio of 3.42 and a beta of 0.84.

Amedisys (NASDAQ:AMED - Get Free Report) last announced its quarterly earnings data on Wednesday, April 24th. The health services provider reported $1.03 earnings per share for the quarter, beating the consensus estimate of $1.02 by $0.01. Amedisys had a positive return on equity of 12.85% and a negative net margin of 0.91%. The business had revenue of $571.41 million during the quarter, compared to analyst estimates of $565.38 million. During the same period in the prior year, the company earned $1.00 earnings per share. Amedisys's revenue was up 2.7% compared to the same quarter last year. As a group, equities analysts predict that Amedisys, Inc. will post 4.57 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the company. Royal Bank of Canada increased their price target on Amedisys from $97.00 to $100.00 and gave the stock an "outperform" rating in a report on Monday, March 25th. Cantor Fitzgerald restated a "neutral" rating and issued a $101.00 target price on shares of Amedisys in a research note on Thursday, April 25th. StockNews.com downgraded Amedisys from a "buy" rating to a "hold" rating in a research note on Friday, April 26th. Finally, Raymond James reissued a "market perform" rating on shares of Amedisys in a research note on Tuesday, March 26th. Eight investment analysts have rated the stock with a hold rating and one has issued a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $97.50.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.